Vaccine development against tuberculosis before and after Covid-19

SHE Kaufmann - Frontiers in Immunology, 2023 - frontiersin.org
Coronavirus disease (Covid-19) has not only shaped awareness of the impact of infectious
diseases on global health. It has also provided instructive lessons for better prevention …

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine

E Underwood, LM Dunkle, SA Madhi… - Expert Review of …, 2023 - Taylor & Francis
Introduction The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and …

XBB. 1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG. 5.1 and emerging XBB variants

N Patel, JF Trost, M Guebre-Xabier, H Zhou… - Scientific Reports, 2023 - nature.com
Abstract Monovalent SARS-CoV-2 Prototype (Wuhan-Hu-1) and bivalent (Prototype+ BA.
4/5) COVID-19 vaccines have demonstrated a waning of vaccine-mediated immunity …

A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates

PS Arunachalam, NY Ha, SM Dennison… - Science Translational …, 2024 - science.org
Authorization of the Matrix-M (MM)–adjuvanted R21 vaccine by three countries and its
subsequent endorsement by the World Health Organization for malaria prevention in …

Microarray patches: scratching the surface of vaccine delivery

JJY Choo, CLD McMillan, PR Young… - Expert Review of …, 2023 - Taylor & Francis
Introduction Microneedles are emerging as a promising technology for vaccine delivery, with
numerous advantages over traditional needle and syringe methods. Preclinical studies have …

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5

TE Harrison, N Alam, B Farrell, D Quinkert… - EMBO Molecular …, 2024 - embopress.org
There is an urgent need for improved malaria vaccine immunogens. Invasion of erythrocytes
by Plasmodium falciparum is essential for its life cycle, preceding symptoms of disease and …

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines

AM Marchese, R Kalkeri, M Vadivale… - Expert Review of …, 2023 - Taylor & Francis
Introduction Approximately half of the 13.4 billion COVID-19 vaccine doses administered
globally were inactivated or viral vector platforms. The harmonization and optimization of …

Unlocking saponin biosynthesis in soapwort

S Jo, A El-Demerdash, C Owen, V Srivastava… - Nature Chemical …, 2024 - nature.com
Soapwort (Saponaria officinalis) is a flowering plant from the Caryophyllaceae family with a
long history of human use as a traditional source of soap. Its detergent properties are …

Precision adjuvants for pediatric vaccines

A Singh, C Boggiano, DE Yin, L Polakowski… - Science Translational …, 2024 - science.org
Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to
enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in …

Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

K Lenart, R Arcoverde Cerveira, F Hellgren, S Ols… - npj Vaccines, 2024 - nature.com
The immune responses to Novavax's licensed NVX-CoV2373 nanoparticle Spike protein
vaccine against SARS-CoV-2 remain incompletely understood. Here, we show in rhesus …